Hiroshi Matsuzaki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Hiroshi Matsuzaki has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Akio Tanaka
Department of Dermatology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
1 shared publication - Chikako Motomura
Department of Pediatrics NHO Fukuoka National Hospital Fukuoka Japan
1 shared publication - Daisuke Yasunari
Department of Pediatrics, National Hospital Organization Fukuoka National Hospital, Fukuoka
1 shared publication - Hajime Tanaka
Department of Urology, Institute of Science Tokyo, Tokyo, Japan
1 shared publication Hiroshi Odajima
Department of Pediatrics, NHO Fukuoka National Hospital, Fukuoka, Japan
1 shared publication- Hiroshi Odajima
Department of Pediatrics, National Hospital Organization Fukuoka National Hospital, Fukuoka
1 shared publication
Latest Publications
- Open Access
- 14 May 2026
- Published by Elsevier in World Allergy Organization Journal
- Vol. 19 (6) , 101396
Trends in the prevalence of childhood allergic diseases in Japan: Comparison of surveys conducted in 1982, 1992, 2002, 2012, and 2022 (WJSAAC phase I–V)
- 14 May 2026
- Published by Elsevier in World Allergy Organization Journal
- Vol. 19 (6) , 101396
Open AccessTrends in the prevalence of childhood allergic diseases in Japan: Comparison of surveys conducted in 1982, 1992, 2002, 2012, and 2022 (WJSAAC phase I–V)
- Open Access
- 1 January 2023
- Published by Japan Medical Association in JMA Journal
- Vol. 6 (2) , 165-174
Prevalence of Allergic Diseases across All Ages in Japan: A Nationwide Cross-Sectional Study Employing Designated Allergic Disease Medical Hospital Network
Allergic diseases affect both children and adults, but generation-specific prevalence rates are unclear. An online questionnaire was used from December 2021 to January 2022 to survey the prevalence of allergic diseases among staff and their families of designated allergic disease medical hospitals in Japan. In this study, bronchial asthma (BA), atopic dermatitis (AD), food allergies (FAs), allergic rhinitis (AR), allergic conjunctivitis (AC), metal allergies (MAs), and drug allergies (DAs) were the allergic diseases surveyed. In total, 18,706 individuals were surveyed (median age, 36 years; quartile range, 18-50). Allergic disease was reported in 62.2% of respondents. Across all ages, prevalence rates were as follows: BA (14.7%), AD (15.6%), FAs (15.2%), AR (47.4%), AC (19.5%), MAs (1.9%), and DAs (4.6%). The prevalence of BA and AR was higher in male children, whereas that of FAs and AC was higher in adult females. The prevalence of MAs and DAs peaked during adulthood and predominated among females. Our results suggest that approximately two-thirds of the Japanese population may have an allergic disease, with AR being the most prevalent.
- 1 January 2023
- Published by Japan Medical Association in JMA Journal
- Vol. 6 (2) , 165-174
Open AccessPrevalence of Allergic Diseases across All Ages in Japan: A Nationwide Cross-Sectional Study Employing Designated Allergic Disease Medical Hospital Network
Allergic diseases affect both children and adults, but generation-specific prevalence rates are unclear. An online questionnaire was used from December 2021 to January 2022 to survey the prevalence of allergic diseases among staff and their families of designated allergic disease medical hospitals in Japan. In this study, bronchial asthma (BA), atopic dermatitis (AD), food allergies (FAs), allergic rhinitis (AR), allergic conjunctivitis (AC), metal allergies (MAs), and drug allergies (DAs) were the allergic diseases surveyed. In total, 18,706 individuals were surveyed (median age, 36 years; quartile range, 18-50). Allergic disease was reported in 62.2% of respondents. Across all ages, prevalence rates were as follows: BA (14.7%), AD (15.6%), FAs (15.2%), AR (47.4%), AC (19.5%), MAs (1.9%), and DAs (4.6%). The prevalence of BA and AR was higher in male children, whereas that of FAs and AC was higher in adult females. The prevalence of MAs and DAs peaked during adulthood and predominated among females. Our results suggest that approximately two-thirds of the Japanese population may have an allergic disease, with AR being the most prevalent.
- Open Access
- 1 April 2022
- Published by Wolters Kluwer Health in Asia Pacific Allergy
- Vol. 12 (2) , e14
Changes in clinical features of food-related anaphylaxis in children during 5 years
Motomura C, et al. Asia Pac Allergy. 2022 Apr;12:e14. https://doi.org/10.5415/apallergy.2022.12.e14
- 1 April 2022
- Published by Wolters Kluwer Health in Asia Pacific Allergy
- Vol. 12 (2) , e14
Open AccessChanges in clinical features of food-related anaphylaxis in children during 5 years
Motomura C, et al. Asia Pac Allergy. 2022 Apr;12:e14. https://doi.org/10.5415/apallergy.2022.12.e14
- 1 July 2002
- Published by Springer Nature in Breast Cancer
- Vol. 9 (3) , 257-260
A case of neurilemmoma of the breast
Neurilemmoma of the breast is rarely seen, although it is common at intracranial or peripheral sites. There have been only 14 cases described in the literature. We present the fifteenth case of a 64-year-old woman with neurilemmoma of the breast, the first to be diagnosed by fine needle aspiration cytology. Fibroadenoma must be distinguished from this tumor. Complete removal is the treatment of choice, considering the possibility of local recurrence and malignant change.
- 1 July 2002
- Published by Springer Nature in Breast Cancer
- Vol. 9 (3) , 257-260
A case of neurilemmoma of the breast
Neurilemmoma of the breast is rarely seen, although it is common at intracranial or peripheral sites. There have been only 14 cases described in the literature. We present the fifteenth case of a 64-year-old woman with neurilemmoma of the breast, the first to be diagnosed by fine needle aspiration cytology. Fibroadenoma must be distinguished from this tumor. Complete removal is the treatment of choice, considering the possibility of local recurrence and malignant change.